Published in Tuberculosis Week, May 24th, 2010
"These tetrahydro-pyridine esters upon dehydrogenation with dichlorodicyanobenzoquinone (DDQ) afforded highly functionalized pyridines in excellent yields. These novel heterocycles were screened for their in vitro activity against Mycobacterium tuberculosis H37Rv using agar dilution method," wrote S.K. Raju and colleagues, Madurai Kamaraj University.
The researchers concluded: "Among the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Tuberculosis Week
Source: Tuberculosis Week (2010-05-24)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.